Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 1 bulk ingredient, 1 drug for further processing. By marketing category: BULK INGREDIENT 1, DRUG FOR FURTHER PROCESSING 1.
| Dosage form | NDCs |
|---|---|
| powder | 2 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| grindeks joint stock company | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Droperidol | powder | 64189-0601BULK INGREDIENT |
| - | oxytocin | powder | 64189-1202DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing droperidol
- American Regent, Inc.5 sites · 70 NDC
Enquiry
Common questions
- Is GRINDEKS Joint Stock Company FDA approved?
- GRINDEKS Joint Stock Company holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does GRINDEKS Joint Stock Company make?
- 2 products are listed under GRINDEKS Joint Stock Company in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.